QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

VALN

QT56Valneva SE
NASDAQ·Healthcare·Biotechnology·FR
Latest market price
5.38
+0.03+0.56%
OverviewShort InterestFilings
VALNQT56Valneva SE·NASDAQ
OverviewShort InterestFilings
5.38+0.56%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-1.90
Insider Own-
Shs Outstand189.77M
Perf Week1.70%
Market Cap504.51MForward P/E7.01EPS next Y0.77Insider Trans-Shs Float-Perf Month-6.60%
Enterprise Value624.03MPEG0.06EPS next Q-0.22Inst Own-Short Float-Perf Quarter-48.76%
Income-174407961.00P/S2.81EPS this Y53.65%Inst Trans-Short Ratio-Perf Half Y-35.49%
Sales179.26MP/B5.21EPS next Y187.13%ROA-37.10%Short Interest-Perf YTD-39.00%
Book/sh0.47P/C-EPS next 5Y-ROE-106.22%52W High12.25 -56.08%Perf Year-8.50%
Cash/sh0.64P/FCF-EPS past 3/5Y-ROIC-36.00%52W Low5.06 6.32%Perf 3Y-
Dividend Est.-EV/EBITDA-6.29Sales past 3/5Y-19.67% 9.35%Gross Margin29.46%Volatility2.25% 3.73%Perf 5Y-
Dividend TTM-EV/Sales3.48EPS Y/Y TTM-916.73%Oper. Margin-68.81%ATR (14)0.25Perf 10Y-
Dividend Ex-Date-Quick Ratio1.60Sales Y/Y TTM-1.09%Profit Margin-88.30%RSI (14)40.37Recom2.00
Dividend Gr. 3/5Y-Current Ratio2.14EPS Q/Q-223.08%SMA20-4.85%Beta1.06Target Price11.00
Payout0.00%Debt/Eq2.73Sales Q/Q-30.77%SMA50-5.59%Rel Volume0.23Prev Close5.35
Employees713LT Debt/Eq1.75EarningsAug 11SMA200-36.61%Avg Volume56.47KPrice5.38
IPO DateMay 05, 2021Option/ShortYes / YesEPS/Sales Surpr.-100.00% -34.55%Net Debt/EBITDA-1.20Volume13,049Change0.56%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-16-26ReiteratedGuggenheimBuy$13 → $11
Aug-25-25ReiteratedJefferies$18 → $14
Mar-24-25ReiteratedGuggenheimBuy$15
Jul-01-24ReiteratedH.C. Wainwright$26
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue181197183
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A128121107
Gross Profit537677
Selling, General and Administrative Excl. Other8284103
Research and Development1009680
Other Operating Expense-13-12-121
Operating Income-115-9214
Interest Expense484726
Unusual Expense
———
Non-Operating Income (Expense)-2-111
Net Income Before Taxes-160-129-12
Income Taxes111
Consolidated Net Income-161-130-13
Net Income From Continuing Operations-161-130-13
Net Income-161-130-13
EPS (Recurring)-1.90-1.49-0.18
EPS (Basic, Before Extraordinaries)-1.90-1.49-0.18
EPS (Diluted)-1.90-1.49-0.18
EBITDA-105-5735
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio2.563.76—
Gross Margin29.2838.5842.08
Operating Margin-63.54-46.707.65
Net Margin-88.95-65.99-7.10
Shares Outstanding868470
Market Capitalization463741—
Operating Lease Expense
———
Insider Trading Volume
$6.12$5.56$5.00$4.44$3.88● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR